By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084



Company News
Advaxis (ADXS) To Receive $1.6 Million Through New Jersey Technology Business Tax (NOL) Program 11/17/2015 11:42:00 AM
Advaxis (ADXS) Presents New Data Featuring Its Lm Technology At The Society For Immunotherapy Of Cancer 2015 Annual Meeting 11/9/2015 12:21:41 PM
Advaxis (ADXS) To Present At The Jefferies Autumn 2015 Global Healthcare Conference 11/5/2015 12:28:46 PM
Advaxis (ADXS) Provides Additional Information On Clinical Hold 11/3/2015 12:46:44 PM
Advaxis (ADXS) Enters Personalized Medicine Space With Memorial Sloan-Kettering Cancer Center Collaboration 10/28/2015 12:22:18 PM
Advaxis (ADXS) Launches Mine Collaboration 10/27/2015 10:34:55 AM
Advaxis (ADXS)’s Cancer Immunotherapies To Be Featured In Three Poster Presentations At The 2015 SITC Annual Meeting 10/13/2015 12:24:13 PM
Death Forces FDA to Place Clinical Hold on Advaxis (ADXS) Cancer Drug 10/6/2015 3:01:58 PM
First Human Patient Treated In Phase 1b Study Of Advaxis, Inc.'s ADXS-HER2 In HER2 Expressing Solid Tumors 9/28/2015 7:55:01 AM
Advaxis, Inc.'s Axalimogene Filolisbac (ADXS-HPV) Showed 38.5 Percent 12-Month Survival In Patients With Persistent/Recurrent Metastatic Cervical Cancer 9/18/2015 6:34:15 AM